Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

MBOT

Microbot Medical (MBOT)

Microbot Medical Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MBOT
FechaHoraFuenteTítuloSímboloCompañía
29/04/202407:30GlobeNewswire Inc.Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™NASDAQ:MBOTMicrobot Medical Inc
15/04/202407:30GlobeNewswire Inc.Microbot Medical Shares Status Following Recent Geopolitical EventsNASDAQ:MBOTMicrobot Medical Inc
26/02/202417:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
20/02/202415:35Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBOTMicrobot Medical Inc
14/02/202413:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MBOTMicrobot Medical Inc
05/02/202406:30GlobeNewswire Inc.Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USNASDAQ:MBOTMicrobot Medical Inc
30/01/202415:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBOTMicrobot Medical Inc
30/01/202406:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
30/01/202406:20GlobeNewswire Inc.Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersNASDAQ:MBOTMicrobot Medical Inc
25/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBOTMicrobot Medical Inc
22/01/202416:20Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MBOTMicrobot Medical Inc
18/01/202406:20GlobeNewswire Inc.Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical StudyNASDAQ:MBOTMicrobot Medical Inc
29/12/202307:00GlobeNewswire Inc.Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq RulesNASDAQ:MBOTMicrobot Medical Inc
28/12/202306:30GlobeNewswire Inc.Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were MetNASDAQ:MBOTMicrobot Medical Inc
14/12/202307:15GlobeNewswire Inc.Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for TeleroboticNASDAQ:MBOTMicrobot Medical Inc
07/12/202307:00GlobeNewswire Inc.Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical StudyNASDAQ:MBOTMicrobot Medical Inc
01/12/202316:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MBOTMicrobot Medical Inc
30/11/202315:31Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:MBOTMicrobot Medical Inc
21/11/202308:12GlobeNewswire Inc.Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial ActivitiesNASDAQ:MBOTMicrobot Medical Inc
17/11/202315:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MBOTMicrobot Medical Inc
13/11/202307:30GlobeNewswire Inc.Microbot Medical Successfully Completed Integral Part of the Verification and Validation ProcessNASDAQ:MBOTMicrobot Medical Inc
08/11/202308:10GlobeNewswire Inc.Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark OfficeNASDAQ:MBOTMicrobot Medical Inc
31/10/202307:25GlobeNewswire Inc.Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical StudyNASDAQ:MBOTMicrobot Medical Inc
24/10/202307:19GlobeNewswire Inc.Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024NASDAQ:MBOTMicrobot Medical Inc
19/10/202307:20GlobeNewswire Inc.Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against CompanyNASDAQ:MBOTMicrobot Medical Inc
17/10/202308:28GlobeNewswire Inc.Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical SystemNASDAQ:MBOTMicrobot Medical Inc
27/09/202307:30GlobeNewswire Inc.Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical TrialNASDAQ:MBOTMicrobot Medical Inc
19/09/202309:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MBOTMicrobot Medical Inc
19/09/202309:45Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MBOTMicrobot Medical Inc
08/09/202309:02GlobeNewswire Inc.Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023NASDAQ:MBOTMicrobot Medical Inc
 Showing the most relevant articles for your search:NASDAQ:MBOT